No correlation between GSH levels in human cancer cell lines and the cell growth inhibitory activities of platinum diamine complexes

Archiv der Pharmazie

Volumn 337, Issue 12, 2004, Pages 668-671

  Boubakari, ^a   Bracht, Karin ^a   Neumann, Christian ^a   Grünert, Renate ^a   Bednarski, Patrick J ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Carboplatin; Cisplatin; Cytotoxicity; Glutathione; Oxaliplatin

Indexed keywords

CARBOPLATIN; CISPLATIN; GLUTATHIONE; OXALIPLATIN; PLATINUM 1,2 DIAMINOCYCLOHEXANE DICHLORIDE; PLATINUM COMPLEX; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; GLUTATHIONE; HUMANS; ORGANOPLATINUM COMPOUNDS;

EID: 11944262305     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200400620     Document Type: Article

References (14)

1. R. P. Perez, Eur. J. Cancer, 1998, 34, 1535-1542.
2. W. S. El-Deiry in Apoptosis and Cancer Chemotherapy (Eds.: J. A. Hickman, C. Dive), Humana Press, Totowa, NJ, 1999, p. 37.
3. R. Brown, in Apoptosis and Cancer Chemotherapy (Eds.: J. A. Hickman, C. Dive) Humana Press, Totowa, NJ, 1999, p. 69.
4. P. A. Andrews, M. P. Murphy, S. B. Howell, Mol. Pharmacol. 1986, 30, 643-650.
5. P. D. Sadowitz, B. A. Hubbard, J. C. Dabrowiak, J. Goodisman, K. A. Tacka, M. K. Aktas, M. J. Cunningham, R. L. Dubowy, A. K. Souid, Drug Metabol. Dispos. 2002, 30, 183-190.
6. C. M. Rudin, Z. Yang, L. M. Schumaker, D. J. Vander-Weele, K. Newkirk, M. J. Egorin, E. G. Zuhowski, K. J. Cullen, Cancer Res., 2003, 63, 312-318.
7. B. A. Teicher, E. Frei in Drug Resistance in the Treatment of Cancer. (Eds.: H. M. Pinedo, G. Giaccone), Cambridge University Press, Cambridge, UK, 1998, p. 14.
8. L. Pendyala, P. J. Creaven, R. Perez, J. R. Zdanowicz, D. Raghavan, Cancer Chemother. Pharamcol. 1995, 36, 271-278.
9. P. G. Parsons, J. Lean, E. P. W. Kable, D. Favier, S. K. Khoo, T. Hurst, R. S. Holmes, A. J. D. Bellet, Biochem. Pharmacol. 1990, 40, 2641-2649.
10. C. Neumann, Boubakari, R. Grünert, P. J. Bednarski, Anal. Biochem. 2003, 320, 170-178.
11. K. D. Paull, R. H. Shoemaker, L. Hodes, A. Monks, D. A. Scudiero, L. Rubinstein, J. Plowman, M. R. Boyd, Natl. Cancer Inst. 1989, 81, 1088-1092.
12. K. Rinke, R. Grünert, P. J. Bednarski, Pharmazie, 2001, 56, 763-769.
13. T. Mosmann, Immunol. Meth. 1983, 65, 55-63.
14. L. L. Havlicek, R. D. Grain in Practical Statistics for the Physical Sciences. ACS, Washington, 1988, p. 432.